Rhythm Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent…
Biotechnology
US, Boston [HQ]

Balance Sheet

11 Sheets · From 2023 to 2012
Configuration
In Million USD. Margins, Growth Rates In %
Metric 2012 2013 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
18.00 18.00 37.00 12.00 151.00 260.00 308.00 187.00 329.00 382.00 332.00
Current
18.00 18.00 35.00 11.00 150.00 258.00 302.00 181.00 308.00 354.00 308.00
Non Current
- - - - 1.00 1.00 1.00 1.00 6.00 5.00 21.00 28.00 24.00
Liabilities
55.00 75.00 5.00 5.00 6.00 13.00 27.00 20.00 45.00 118.00 162.00
Current
2.00 3.00 5.00 4.00 6.00 13.00 24.00 17.00 43.00 39.00 55.00
Non Current
52.00 72.00 - - - - - - - - 3.00 2.00 1.00 78.00 107.00
Equity
-36.00 -57.00 32.00 7.00 144.00 246.00 281.00 166.00 284.00 264.00 169.00
Stockholders' Equity
-36.00 -57.00 32.00 7.00 144.00 246.00 281.00 166.00 284.00 264.00 169.00
Retained Earnings
-37.00 -58.00 -50.00 -76.00 -110.00 -184.00 -325.00 -459.00 -528.00 -710.00 -894.00
Common Stock
- - - - - - - - - - - - - - - - - - - - - -
Preferred Stock
- - - - 40.00 40.00 151.00 260.00 - - - - - - - - - -
Profit
-18.00 -21.00 -11.00 -25.00 -33.00 -74.00 -134.00 -130.00 -68.00 -183.00 -184.00
Dividends
- - - - - - - - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
- - - - 42.00 43.00 103.00 171.00 606.00 625.00 813.00 974.00 1,064.00
Loss Other Compr. Income
- - - - - - - - - - - - - - - - - - - - - -